PDCD1 and melanoma: Immunotherapy by blocking the axis of the immune checkpoint molecule programmed cell death protein (PD1) or its ligand PDL1 has presented remarkable survival benefit and thus became a frontline treatment for metastatic or unresectable melanoma [1, 2].